FDA Drug Application (072022) for TRIAMTERENE AND HYDROCHLOROTHIAZIDE by AM THERAP

Back to FDA Applications sponsored by AM THERAP

Application Number072022
Product Number001
FormTABLET;ORAL
Dosage50MG;75MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE



Back to FDA Applications sponsored by AM THERAP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.